Warning letter
Avlon Industries, Inc.: warning letter of Jul 18, 2023
FDA warning letter 652903 · Division of Pharmaceutical Quality Operations III
Key facts
| Reference number | 652903 |
|---|---|
| Company | Avlon Industries, Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Jul 18, 2023 |
| Posted date | Aug 1, 2023 |
| Issuing office | Division of Pharmaceutical Quality Operations III |
| Product type | Drugs |
| CFR sections cited | 211.22, 211.34, 211.84(d)(1), 211.100(a) |
| Inspection city | Melrose Park |
| Inspection ZIP | 60160 |
| Inspection start date | Jan 17, 2023 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: